| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 4,497,000 | 4,169,000 | 3,569,000 | 4,315,000 | | Cost of Revenue | 3,877,000 | 3,615,000 | 3,045,000 | 3,842,000 | | | Gross Profit | 620,000 | 554,000 | 524,000 | 473,000 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 400,000 | 390,000 | 327,000 | 379,000 | | Non Recurring | 24,000 | 23,000 | 24,000 | 77,000 | | Others | 7,000 | 7,000 | 7,000 | 7,000 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 189,000 | 134,000 | 166,000 | 10,000 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (51,000) | (59,000) |
-
| 150,000 | | Earnings Before Interest And Taxes | 138,000 | 75,000 | 166,000 | 160,000 | | Interest Expense | 58,000 | 11,000 | 109,000 | 269,000 | | Income Before Tax | 80,000 | 64,000 | 57,000 | (109,000) | | Income Tax Expense | (13,000) | (22,000) | (16,000) | (160,000) | | Minority Interest | 13,000 | (13,000) |
-
| (7,000) | | | | Net Income From Continuing Ops | 106,000 | 73,000 | 73,000 | 44,000 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 106,000 | 73,000 | 73,000 | 44,000 | | Preferred Stock And Other Adjustments | (19,000) | 5,000 | (5,000) |
-
| | | Net Income Applicable To Common Shares | $87,000 | $78,000 | $68,000 | $44,000 |
|
0.29% Nasdaq 
Income Statement
